A Case-Study on the Photophysics of Chalcogen-Substituted Zinc(II) Phthalocyanines.

Singlet dioxygen has been widely applied in different disciplines such as medicine (photodynamic therapy or blood sterilization), remediation (wastewater treatment) or industrial processes (fine chemicals synthesis). Particularly, it can be conveniently generated by energy transfer between a photosensitizer's triplet state and triplet dioxygen upon irradiation with visible light. Among the best photosensitizers, substituted zinc(II) phthalocyanines are prominent due to their excellent photophysical properties, which can be tuned by structural modifications, such as halogen- and chalcogen-atom substitution. These patterns allow for the enhancement of spin-orbit coupling, commonly attributed to the heavy atom effect, which correlates with the atomic number ( Z ${Z}$ ) and the spin-orbit coupling constant ( ζ ${\zeta }$ ) of the introduced heteroatom. Herein, a fully systematic analysis of the effect exerted by chalcogen atoms on the photophysical characteristics (absorption and fluorescence properties, lifetimes and singlet dioxygen photogeneration), involving 30 custom-made ß-tetrasubstituted chalcogen-bearing zinc(II) phthalocyanines is described and evaluated regarding the heavy atom effect. Besides, the intersystem crossing rate constants are estimated by several independent methods and a quantitative profile of the heavy atom is provided by using linear correlations between relative intersystem crossing rates and relative atomic numbers. Good linear trends for both intersystem crossing rates (S1-T1 and T1-S0) were obtained, with a dependency on the atomic number and the spin-orbit coupling constant scaling as Z 0 . 4 ${{Z}^{0.4}}$ and ζ 0 . 2 ${{\zeta }^{0.2}}$ , respectively The trend shows to be independent of the solvent and temperature.

[Inpatient Equivalent Home Treatment (IEHT) compared to inpatient psychiatric treatment: 12-month follow-up results of a retrospectively matched cohort study using propensity score]. / Stationsäquivalente Behandlung (StäB) im Vergleich mit vollstationärer Behandlung: 12-Monats-Follow-up Ergebnisse einer mittels Propensity-Score gematchten retrospektiven Kohortenstudie.

AIM OF THE STUDY: Comparison of psychiatric services use in the 12-month follow-up period between Inpatient Equivalent Home Treatment (IEHT) and inpatient psychiatric treatment. METHODS: In a retrospective 12-month follow-up study, 223 patients from the Inpatient Equivalent Home Treatment (IEHT) intervention group (IG) were compared to a matched inpatient control group (CG) on their utilization of psychiatric services. RESULTS: The inpatient readmission rate in the IG was significantly 11% lower than in the CG. The number of treatment days in the IG was significantly lower than in the CG. In the IG, psychiatric services at the outpatient clinic were used significantly more often for the first time than in the CG. CONCLUSION: The present study suggests that IEHT is superior to inpatient treatment in terms of the risk of inpatient readmission and the duration of inpatient treatment days. An outpatient services use effect following IEHT is observed.

R2022: A DFT/MRCI Ansatz with Improved Performance for Double Excitations.

A reformulation of the combined density functional theory and multireference configuration interaction method (DFT/MRCI) is presented. Expressions for ab initio matrix elements are used to derive correction terms for a new effective Hamiltonian. On the example of diatomic carbon, the correction terms are derived, focusing on the doubly excited 1Δg state, which was problematic in previous formulations of the method, as were double excitations in general. The derivation shows that a splitting of the parameters for intra- and interorbital interactions is necessary for a concise description of the underlying physics. Results for 1La and 1Lb states in polyacenes and 1Au and 1Ag states in mini-ß-carotenoids suggest that the presented formulation is superior to former effective Hamiltonians. Furthermore, statistical analysis reveals that all the benefits of the previous DFT/MRCI Hamiltonians are retained. Consequently, the here presented formulation should be considered as the new standard for DFT/MRCI calculations.

Identification and evaluation of a novel tribenzamide derivative as an inhibitor targeting the entry of the respiratory syncytial virus.

Human respiratory syncytial virus (RSV) is the leading cause of severe lower respiratory tract infections in infants, the elderly, and the immunocompromised, yet no licensed vaccine and only limited therapeutic options for prevention and treatment are available, which poses a global health challenge and emphasizes the urgent medical need for novel antiviral agents. In the current study, a novel potent small molecule inhibitor of RSV was identified by performing a screening and structure optimization campaign, wherein a naturally occurring dicaffeoylquinic acid (DCQA) compound served as a chemical starting point. The reported benzamide derivative inhibitor, designated as 2f, was selected for its improved stability and potent antiviral activity from a series of investigated structurally related compounds. 2f was well tolerated by cells and able to inhibit RSV infection with a half maximal inhibitory concentration (IC50) of 35 nM and a favorable selectivity index (SI) of 3742. Although the exact molecular target for 2f is not known, in vitro mechanism of action investigations revealed that the compound inhibits the early stage of infection by interacting with RSV virion and interferes primarily with the attachment and potentially with the virus-cell fusion step. Moreover, intranasal administration of 2f to mice simultaneously or prior to intranasal infection with RSV significantly decreased viral load in the lungs, pointing to the in vivo potential of the compound. Our results suggest that 2f is a viable candidate for further preclinical development and evaluation as an antiviral agent against RSV infections.

[Evidence on the effects of crisis resolution teams, home treatment and assertive outreach for people with mental disorders in Germany, Austria and Switzerland - a systematic review]. / Evidenz zu aufsuchender Behandlung bei Menschen mit psychischen Störungen in Deutschland, Österreich und der Schweiz ­ eine systematische Übersichtsarbeit.

BACKGROUND: Based on international randomized controlled trials (RCT) the German Association for Psychiatry, Psychotherapy and Psychosomatics (DGPPN) recommends acute treatment in the domestic environment (AHU) and intensive outreach treatment (IAB) with the highest level of evidence; however, due to large differences in national healthcare systems the transference of results from international studies to the healthcare systems in Germany, Austria and Switzerland could be limited. OBJECTIVE: Evaluation of studies on outreach psychiatric treatment forms in Germany, Austria and Switzerland and discussion of the results in the light of international evidence. MATERIAL AND METHODS: A systematic literature search for clinical trials on outreach community treatment from Germany, Austria and Switzerland was conducted in the PubMed database. RESULTS: A total of 19 publications were identified which could be assigned to 5 publications on 4 studies with 2857 patients on AHU and 14 publications on 10 studies with 3207 patients on IAB. The studies on AHU showed this treatment form to be superior regarding the duration of inpatient stay and healthcare costs. The studies on IAB showed more positive outcomes in comparison to controls regarding symptoms, severity of illness, substance abuse, functioning level, remission, satisfaction with treatment, quality of life, healthcare costs, work and housing situations. CONCLUSION: The studies from Germany, Austria, and Switzerland suggest that outreach community treatment is superior regarding several outcome parameters. Thus, there are no indications suggesting that international evidence could not be valid for these countries. Additionally, with one RCT for AHU and one for IAB the requirements for an evidence level of 1b for outreach community treatment in the healthcare systems in question are fulfilled.

[Comparison of Inpatient Equivalent Home Treatment (IEHT) with Standard Inpatient Treatment: A Matched Cohort Study]. / Stationsäquivalente Behandlung (StäB) im Vergleich mit vollstationärer Behandlung: 12-Monats-Follow-up einer gematchten Kohortenstudie.

OBJECTIVE: Effectiveness of Inpatient Equivalent Home Treatment (IEHT) was examined in comparison to standard psychiatric inpatient treatment. IEHT is similar to the internationally known Home Treatment or Crisis Resolution Teams. It provides acute psychiatric treatment at the user's home, similar to inpatient hospital treatment in terms of content, flexibility, and complexity. METHODS: This retrospective matched control study used routine data of 86 patients (IEHT, n = 43, standard inpatient treatment n = 43). Readmission rates and cumulative hospital days were compared within a 12-month-follow-up time period. RESULTS: The readmission rate was lower and cumulative treatment days were longer after IETH. However, both group differences were not statistically significant. CONCLUSION: The present study indicates that IEHT is not inferior to standard inpatient treatment in terms of the risk of readmission.

Large Inverted Singlet-Triplet Energy Gaps Are Not Always Favorable for Triplet Harvesting: Vibronic Coupling Drives the (Reverse) Intersystem Crossing in Heptazine Derivatives.

Heptazine derivatives are promising dopants for electroluminescent devices. Recent studies raised the question whether heptazines exhibit a small regular or an inverted singlet-triplet (IST) gap. It was argued that the S1 ← T1 reverse intersystem crossing (RISC) is a downhill process in IST emitters and therefore does not require thermal activation, thus enabling efficient harvesting of triplet excitons. Rate constants were not determined in these studies. Modeling the excited-state properties of heptazine proves challenging because fluorescence and intersystem crossing (ISC) are symmetry-forbidden in first order. In this work, we present a comprehensive theoretical study of the photophysics of heptazine and its derivative HAP-3MF. The calculations of electronic excitation energies and vibronic coupling matrix elements have been conducted at the density functional theory/multireference configuration interaction (DFT/MRCI) level of theory. We have employed a finite difference approach to determine nonadiabatic couplings and derivatives of spin-orbit coupling and electric dipole transition matrix elements with respect to normal coordinate displacements. Kinetic constants for fluorescence, phosphorescence, internal conversion (IC), ISC, and RISC have been computed in the framework of a static approach. Radiative S1 ↔ S0 transitions borrow intensity mainly from optically bright E' π → π* states, while S1 ↔ T1 (R)ISC is mediated by E″ states of n → π* character. Test calculations show that IST gaps as large as those reported in the literature are counterproductive and slow down the S1 ← T1 RISC process. Using the adiabatic DFT/MRCI singlet-triplet splitting of -0.02 eV, we find vibronically enhanced ISC and RISC to be fast in the heptazine core compound. Nevertheless, its photo- and electroluminescence quantum yields are predicted to be very low because S1 → S0 IC efficiently quenches the luminescence. In contrast, fluorescence, IC, ISC, and RISC proceed at similar time scales in HAP-3MF.

Internal conversion of singlet and triplet states employing numerical DFT/MRCI derivative couplings: Implementation, tests, and application to xanthone.

We present an efficient implementation of nonadiabatic coupling matrix elements (NACMEs) for density functional theory/multireference configuration interaction (DFT/MRCI) wave functions of singlet and triplet multiplicity and an extension of the Vibes program that allows us to determine rate constants for internal conversion (IC) in addition to intersystem crossing (ISC) nonradiative transitions. Following the suggestion of Plasser et al. [J. Chem. Theory Comput. 12, 1207 (2016)], the derivative couplings are computed as finite differences of wave function overlaps. Several measures have been taken to speed up the calculation of the NACMEs. Schur's determinant complement is employed to build up the determinant of the full matrix of spin-blocked orbital overlaps from precomputed spin factors with fixed orbital occupation. Test calculations on formaldehyde, pyrazine, and xanthone show that the mutual excitation level of the configurations at the reference and displaced geometries can be restricted to 1. In combination with a cutoff parameter of tnorm = 10-8 for the DFT/MRCI wave function expansion, this approximation leads to substantial savings of cpu time without essential loss of precision. With regard to applications, the photoexcitation decay kinetics of xanthone in apolar media and in aqueous solution is in the focus of the present work. The results of our computational study substantiate the conjecture that S1 T2 reverse ISC outcompetes the T2 ↝ T1 IC in aqueous solution, thus explaining the occurrence of delayed fluorescence in addition to prompt fluorescence.

Structure and Dynamics of Meprin ß in Complex with a Hydroxamate-Based Inhibitor.

The astacin protease Meprin ß represents an emerging target for drug development due to its potential involvement in disorders such as acute and chronic kidney injury and fibrosis. Here, we elaborate on the structural basis of inhibition by a specific Meprin ß inhibitor. Our analysis of the crystal structure suggests different binding modes of the inhibitor to the active site. This flexibility is caused, at least in part, by movement of the C-terminal region of the protease domain (CTD). The CTD movement narrows the active site cleft upon inhibitor binding. Compared with other astacin proteases, among these the highly homologous isoenzyme Meprin α, differences in the subsites account for the unique selectivity of the inhibitor. Although the inhibitor shows substantial flexibility in orientation within the active site, the structural data as well as binding analyses, including molecular dynamics simulations, support a contribution of electrostatic interactions, presumably by arginine residues, to binding and specificity. Collectively, the results presented here and previously support an induced fit and substantial movement of the CTD upon ligand binding and, possibly, during catalysis. To the best of our knowledge, we here present the first structure of a Meprin ß holoenzyme containing a zinc ion and a specific inhibitor bound to the active site. The structural data will guide rational drug design and the discovery of highly potent Meprin inhibitors.

Acridones: Strongly Emissive HIGHrISC Fluorophores.

An acridone derivative (N-methyl-difluoro-acridone, NMA-dF) is characterized with respect to its utility as an emitter in organic light emitting diodes (OLEDs). Using steady-state and time-resolved spectroscopy as well as quantum chemistry, its ability to convert singlet and triplet excitons into light was scrutinized. NMA-dF emits in the deep blue range of the visible spectrum. Its fluorescence emission occurs with quantum yields close to 1 and a radiative rate constant of ≈5 × 108 s-1. So, it processes singlet excitons very efficiently. Using 1,4-dichlorobenzene as a sensitizer, it is shown that NMA-dF also converts triplet excitons into light. With the aid of quantum chemistry, this is related to a reverse intersystem crossing starting from a higher triplet state (HIGHrISC).

Targeting isoaspartate-modified Aß rescues behavioral deficits in transgenic mice with Alzheimer's disease-like pathology.

BACKGROUND: Amyloid ß (Aß)-directed immunotherapy has shown promising results in preclinical and early clinical Alzheimer's disease (AD) trials, but successful translation to late clinics has failed so far. Compelling evidence suggests that post-translationally modified Aß peptides might play a decisive role in onset and progression of AD and first clinical trials targeting such Aß variants have been initiated. Modified Aß represents a small fraction of deposited material in plaques compared to pan-Aß epitopes, opening up pathways for tailored approaches of immunotherapy. Here, we generated the first monoclonal antibodies that recognize L-isoaspartate-modified Aß (isoD7-Aß) and tested a lead antibody molecule in 5xFAD mice. METHODS: This work comprises a combination of chemical and biochemical techniques as well as behavioral analyses. Aß peptides, containing L-isoaspartate at position 7, were chemically synthesized and used for immunization of mice and antibody screening methods. Biochemical methods included anti-isoD7-Aß monoclonal antibody characterization by surface plasmon resonance, immunohistochemical staining of human and transgenic mouse brain, and the development and application of isoD7-Aß ELISA as well as different non-modified Aß ELISA. For antibody treatment studies, 12 mg/kg anti-isoD7-Aß antibody K11_IgG2a was applied intraperitoneally to 5xFAD mice for 38 weeks. Treatment controls implemented were IgG2a isotype as negative and 3D6_IgG2a, the parent molecule of bapineuzumab, as positive control antibodies. Behavioral studies included elevated plus maze, pole test, and Morris water maze. RESULTS: Our advanced antibody K11 showed a KD in the low nM range and > 400fold selectivity for isoD7-Aß compared to other Aß variants. By using this antibody, we demonstrated that formation of isoD7-Aß may occur after formation of aggregates; hence, the presence of the isoD7-modification differentiates aged Aß from newly formed peptides. Importantly, we also show that the Tottori mutation responsible for early-onset AD in a Japanese pedigree is characterized by massively accelerated formation of isoD7-Aß in cell culture. The presence of isoD7-Aß was verified by K11 in post mortem human cortex and 5xFAD mouse brain tissue. Passive immunization of 5xFAD mice resulted in a significant reduction of isoD7-Aß and total Aß in brain. Amelioration of cognitive impairment was demonstrated by Morris water maze, elevated plus maze, pole, and contextual fear conditioning tests. Interestingly, despite the lower abundance of the isoD7-Aß epitope, the application of anti-isoD7-Aß antibodies showed comparable treatment efficacy in terms of reduction of brain amyloid and spatial learning but did not result in an increase of plasma Aß concentration as observed with 3D6 treatment. CONCLUSIONS: The present study demonstrates, for the first time, that the antibody-mediated targeting of isoD7-modified Aß peptides leads to attenuation of AD-like amyloid pathology. In conjunction with previously published data on antibodies directed against pGlu-modified Aß, the results highlight the crucial role of modified Aß peptides in AD pathophysiology. Hence, the results also underscore the therapeutic potential of targeting modified amyloid species for defining tailored approaches in AD therapy.

Visible Light-Induced Homolytic Cleavage of Perfluoroalkyl Iodides Mediated by Phosphines.

In an effort to explain the experimentally observed variation of the photocatalytic activity of t Bu 3 P, n Bu 3 P and (MeO) 3 P in the blue-light regime [Helmecke et al., Org. Lett. 21 (2019) 7823], we have explored the absorption characteristics of several phosphine- and phosphite-IC 4 F 9 adducts by means of relativistic density functional theory and multireference configuration interaction methods. Based on the results of these computational and complementary experimental studies, we offer an explanation for the broad tailing of the absorption of t Bu 3 P-IC 4 F 9 and (MeO) 3 P-IC 4 F 9 into the visible-light region. Larger coordinate displacements of the ground and excited singlet potential energy wells in n Bu 3 P-IC 4 F 9 , in particular with regard to the P-I-C bending angle, reduce the Franck-Condon factors and thus the absorption probability compared to t Bu 3 P-IC 4 F 9 . Spectroscopic and computational evaluation of conformationally flexible and locked phosphites suggests that the reactivity of (MeO) 3 P may be the result of oxygen lone-pair participation and concomitant broadening of absorption. The proposed mechanism for the phosphine-catalyzed homolytic C-I cleavage of perfluorobutane iodide involves S1 ← S0 absorption of the adduct followed by intersystem crossing to the photochemically active T 1 state.

Development of the clinical candidate PBD-C06, a humanized pGlu3-Aß-specific antibody against Alzheimer's disease with reduced complement activation.

In clinical trials with early Alzheimer's patients, administration of anti-amyloid antibodies reduced amyloid deposits, suggesting that immunotherapies may be promising disease-modifying interventions against Alzheimer's disease (AD). Specific forms of amyloid beta (Aß) peptides, for example post-translationally modified Aß peptides with a pyroglutamate at the N-terminus (pGlu3, pE3), are attractive antibody targets, due to pGlu3-Aß's neo-epitope character and its propensity to form neurotoxic oligomeric aggregates. We have generated a novel anti-pGlu3-Aß antibody, PBD-C06, which is based on a murine precursor antibody that binds with high specificity to pGlu3-Aß monomers, oligomers and fibrils, including mixed aggregates of unmodified Aß and pGlu3-Aß peptides. PBD-C06 was generated by first grafting the murine antigen binding sequences onto suitable human variable light and heavy chains. Subsequently, the humanized antibody was de-immunized and site-specific mutations were introduced to restore original target binding, to eliminate complement activation and to improve protein stability. PBD-C06 binds with the same specificity and avidity as its murine precursor antibody and elimination of C1q binding did not compromise Fcγ-receptor binding or in vitro phagocytosis. Thus, PBD-C06 was specifically designed to target neurotoxic aggregates and to avoid complement-mediated inflammatory responses, in order to lower the risk for vasogenic edemas in the clinic.

Effector function of anti-pyroglutamate-3 Aß antibodies affects cognitive benefit, glial activation and amyloid clearance in Alzheimer's-like mice.

BACKGROUND: Pyroglutamate-3 Aß (pGlu-3 Aß) is an N-terminally truncated and post-translationally modified Aß species found in Alzheimer's disease (AD) brain. Its increased peptide aggregation propensity and toxicity make it an attractive emerging treatment strategy for AD. We address the question of how the effector function of an anti-pGlu-3 Aß antibody influences the efficacy of immunotherapy in mouse models with AD-like pathology. METHODS: We compared two different immunoglobulin (Ig) isotypes of the same murine anti-pGlu-3 Aß mAb (07/1 IgG1 and 07/2a IgG2a) and a general N-terminal Aß mAb (3A1 IgG1) for their ability to clear Aß and protect cognition in a therapeutic passive immunotherapy study in aged, plaque-rich APPSWE/PS1ΔE9 transgenic (Tg) mice. We also compared the ability of these antibodies and a CDC-mutant form of 07/2a (07/2a-k), engineered to avoid complement activation, to clear Aß in an ex vivo phagocytosis assay and following treatment in APPSLxhQC double Tg mice, and to activate microglia using longitudinal microPET imaging with TSPO-specific 18F-GE180 tracer following a single bolus antibody injection in young and old Tg mice. RESULTS: We demonstrated significant cognitive improvement, better plaque clearance, and more plaque-associated microglia in the absence of microhemorrhage in aged APPSWE/PS1ΔE9 Tg mice treated with 07/2a, but not 07/1 or 3A1, compared to PBS in our first in vivo study. All mAbs cleared plaques in an ex vivo assay, although 07/2a promoted the highest phagocytic activity. Compared with 07/2a, 07/2a-k showed slightly reduced affinity to Fcγ receptors CD32 and CD64, although the two antibodies had similar binding affinities to pGlu-3 Aß. Treatment of APPSLxhQC mice with 07/2a and 07/2a-k mAbs in our second in vivo study showed significant plaque-lowering with both mAbs. Longitudinal 18F-GE180 microPET imaging revealed different temporal patterns of microglial activation for 3A1, 07/1, and 07/2a mAbs and no difference between 07/2a-k and PBS-treated Tg mice. CONCLUSION: Our results suggest that attenuation of behavioral deficits and clearance of amyloid is associated with strong effector function of the anti-pGlu-3 Aß mAb in a therapeutic treatment paradigm. We present evidence that antibody engineering to reduce CDC-mediated complement binding facilitates phagocytosis of plaques without inducing neuroinflammation in vivo. Hence, the results provide implications for tailoring effector function of humanized antibodies for clinical development.

The simulation of X-ray absorption spectra from ground and excited electronic states using core-valence separated DFT/MRCI.

We present an extension of the combined density functional theory (DFT) and multireference configuration interaction (MRCI) method (DFT/MRCI) [S. Grimme and M. Waletzke, J. Chem. Phys. 111, 5645 (1999)] for the calculation of core-excited states based on the core-valence separation (CVS) approximation. The resulting method, CVS-DFT/MRCI, is validated via the simulation of the K-edge X-ray absorption spectra of 40 organic chromophores, amino acids, and nucleobases, ranging in size from CO2 to tryptophan. Overall, the CVS-DFT/MRCI method is found to yield accurate X-ray absorption spectra (XAS), with consistent errors in peak positions of ∼2.5-3.5 eV. Additionally, we show that the CVS-DFT/MRCI method may be employed to simulate XAS from valence excited states and compare the simulated spectra to those computed using the established wave function-based approaches [ADC(2) and ADC(2)x]. In general, each of the methods yields excited state XAS spectra in qualitative and often quantitative agreement. In the instances where the methods differ, the CVS-DFT/MRCI simulations predict intensity for transitions for which the underlying electronic states are characterized by doubly excited configurations relative to the ground state configuration. Here, we aim to demonstrate that the CVS-DFT/MRCI approach occupies a specific niche among numerous other electronic structure methods in this area, offering the ability to treat initial states of arbitrary electronic character while maintaining a low computational cost and comparatively black box usage.

Impact of fluorination on the photophysics of the flavin chromophore: a quantum chemical perspective.

10-Methylisoalloxazine (MIA) and its mono-fluorinated derivatives (6-9F-MIA) were investigated by means of quantum chemistry, looking into the influence of fluorination on fluorescence, absorption and inter-system crossing (ISC). A maximized fluorescence quantum yield (ΦFl) of this chromophore is desirable for application as a potential fluorescence marker in biodiagnostics/photobiological studies. An enhanced triplet quantum yield ΦT on the other hand may open a perspective for photodynamic therapies (PDT) in cancer treatment. Determination of equilibrium geometries was carried out employing (time-dependent) Kohn-Sham density functional theory and electronic properties were obtained using a combined density functional theory and multi-reference configuration interaction (DFT/MRCI) method. In the gas phase, El-Sayed-favored 1(ππ*) [radiolysis arrow - arrow with voltage kink] 3(nπ*)-ISC enables population transfer to the triplet domain on a timescale of 109 s-1, i.e. significantly faster than fluorescence (kFl ≈ 107 s-1). Two different models were applied to investigate the influence of aqueous medium on absorption and relaxation: the implicit solvation model A is the well-established conductor-like screening model (COSMO) and hybrid model B combines quantum mechanical micro-hydration and conductor-like screening. A polar, protic environment leads to a significant blue-shift of the nπ* potentials, slowing down the ISC process to 107-108 s-1, now enabled by vibronic spin-orbit coupling. Simple principles are derived that demonstrate the effect of fluorination at different positions on the spectroscopic properties. These principles can be utilized with respect to multiply fluorinated derivatives and even further substitution to enlarge effects on the population decay and quantum yields.

On the performance of DFT/MRCI Hamiltonians for electronic excitations in transition metal complexes: The role of the damping function.

The combination of density functional theory and multireference configuration interaction (DFT/MRCI) is a well-established semi-empirical method suitable for computing spectral properties of large molecular systems. To this day, three different Hamiltonians and various parameter set combinations exist. These DFT/MRCI variants are well tried and tested when it comes to electronic excitations of organic molecules. For transition metal complexes, systematic benchmarks against experimental data are missing, however. Here we present an assessment of the DFT/MRCI variants and of time-dependent, linear-response density functional theory (TDDFT) for a diverse set of ligand-centered, metal-to-ligand charge transfer, metal-centered, and ligand-to-metal charge transfer (LMCT) excitations on 21 3d and 4d complexes comprising 10 small inorganic and 11 larger metalorganic compounds with closed-shell ground states. In the course of this assessment, we realized that the excitation energies of transition metal complexes can be very sensitive with respect to the details of the damping function that scales off-diagonal matrix elements. This scaling is required in DFT/MRCI to avoid double counting of dynamic electron correlation. These insights lead to a new Hamiltonian, denoted R2018, with improved performance on transition metal compounds, while the results for organic molecules are nearly unaffected by the modified damping function. Two parameter sets were optimized for this Hamiltonian: One set is to be used in conjunction with the standard configuration selection threshold of 1.0 E h and a second set is for use with a selection threshold of 0.8 E h which leads to shorter wave function expansions. The R2018 Hamiltonian in standard parameterization achieves root-mean-square errors (RMSEs) of merely 0.15 eV for the metalorganic complexes, followed by 0.20 eV for the original DFT/MRCI ansatz, and 0.25 eV for the redesigned DFT/MRCI approach. In comparison, TDDFT gives a much larger RMSE of 0.46 eV for metalorganic complexes. None of the DFT/MRCI variants yields convincing results for small oxides and fluorides which exhibit LMCT transitions. Here, TDDFT performs better. If the oxides and fluorides are excluded from the inorganic test set, satisfactory agreement can be achieved, with RMSE values between 0.26 eV and 0.30 eV for DFT/MRCI and 0.34 eV for TDDFT. The performance of the original and the new DFT/MRCI Hamiltonians deteriorates only slightly, when a tighter selection threshold is chosen, thus enabling the computation of reliable spectral properties even for large metalorganic complexes.

Plant-made Salmonella bacteriocins salmocins for control of Salmonella pathovars.

Salmonella enterica causes an estimated 1 million illnesses in the United States each year, resulting in 19,000 hospitalizations and 380 deaths, and is one of the four major global causes of diarrhoeal diseases. No effective treatments are available to the food industry. Much attention has been given to colicins, natural non-antibiotic proteins of the bacteriocin class, to control the related pathogen Escherichia coli. We searched Salmonella genomic databases for colicin analogues and cloned and expressed in plants five such proteins, which we call salmocins. Among those, SalE1a and SalE1b were found to possess broad antimicrobial activity against all 99 major Salmonella pathovars. Each of the two salmocins also showed remarkably high potency (>106 AU/µg recombinant protein, or >103 higher than colicins) against major pathogenic target strains. Treatment of poultry meat matrices contaminated with seven key pathogenic serovars confirmed salmocin efficacy as a food safety intervention against Salmonella.